Metronidasool is a word that sends many English-speaking searchers down a confusing path, but the answer is reassuringly simple: it is the Estonian-language name for metronidazole, a well-known antimicrobial medicine. It is not a different drug, not a new drug, and not a separate brand. If you have encountered the word on foreign medicine information, pharmacy material, or a medical website, you have simply met a familiar medicine under its Estonian name. This briefing explains what that medicine is, what it is used for, what its known side effects and cautions are, and — importantly — what this article cannot tell you, because dosing and treatment decisions belong to a qualified healthcare professional, not to a news-magazine briefing.
A medical note up front, stated plainly: this article is general information only. It does not diagnose, prescribe, or replace professional advice. If you have been prescribed a medicine under this name, follow the instructions given by your prescriber and pharmacist, and ask them — not a search result — about anything you are unsure of.
Key facts at a glance
What we know: metronidasool and metronidazole refer to the same active ingredient, a nitroimidazole antimicrobial. It works against certain anaerobic bacteria — bacteria that thrive in oxygen-free environments — and certain protozoal parasites, by damaging their DNA and stopping them from growing. It is available in several forms, including tablets, liquid, creams, gels, vaginal preparations, and injection, depending on the condition being treated and the country. What we do not know from a general briefing, and what you should never guess: the right dose, form, or duration for any individual, because those depend on the infection, the patient, and local prescribing guidance. Any article that gives you a personal dose for metronidasool without knowing your situation is overstepping.
What we know: what metronidazole treats
Metronidazole’s approved uses, as listed in established drug references, cover a defined set of conditions rather than infections in general. They include symptomatic trichomoniasis in adults, confirmed by laboratory testing, and treatment of asymptomatic sexual partners at the same time to prevent reinfection. They include amoebiasis — both acute intestinal amoebic dysentery and amoebic liver abscess — in adults and children. They include serious anaerobic bacterial infections, including infections inside the abdomen, skin, gynaecological, lower respiratory, central nervous system, and bloodstream infections, as well as endocarditis and bone and joint infections, usually as add-on therapy. The injection form is also used to prevent infection around elective bowel surgery, given before, during, and after contaminated or potentially contaminated colorectal surgery and stopped within a defined window after the operation.
Topical forms have their own uses. Metronidazole gel and cream are used on the skin for rosacea, a long-term skin condition causing facial redness, and vaginal gel is used for bacterial infections of the vagina. These topical uses are not interchangeable with tablets: the form matters, the condition matters, and a preparation meant for one site should not be used on another without professional advice.
Just as important is what metronidazole does not treat. It has no clinically relevant activity against the oxygen-loving bacteria behind most everyday urinary and chest infections, which is why it is not used for those. It does not treat viral illnesses such as colds or flu, and it will not treat a vaginal yeast infection. Unnecessary antibiotic use contributes to antimicrobial resistance, which is why this medicine, like other antimicrobials, should only be used when it is genuinely indicated.
What we know: side effects and cautions
The most commonly reported side effects are gastrointestinal and sensory: nausea, and a metallic taste in the mouth, are frequently mentioned in patient guidance. Other effects are listed in formal references, and their likelihood depends on dose, duration, and the individual. The well-known interaction is with alcohol: alcohol should be avoided during relevant metronidazole treatment, and guidance commonly extends that avoidance for at least a day after stopping, because the combination can cause unpleasant effects such as a fast heartbeat, warmth or redness under the skin, tingling, nausea, and vomiting. Foods or medicines containing propylene glycol are also flagged in some guidance for the same reason.
Other cautions in established references include allergy to metronidazole itself, and the recent use of disulfiram, a medicine used in alcohol dependence, within the past two weeks — a combination that should be avoided. Nervous-system effects, including seizures and other neurological symptoms such as headaches, visual changes, weakness, numbness, or tingling, have been reported; guidance says to stop the medicine and seek medical advice immediately if such symptoms appear. Animal studies have also raised a carcinogenicity question historically, with tumours reported in mice and rats, though whether that risk applies to people using the medicine is not established — a nuance that is often lost when the point is quoted without context. As always, the prescriber weighs these factors for the individual patient.
What we know: the name question
Why does the same medicine have two names at all? Because drug names are localised. International nonproprietary names such as metronidazole are the global standard, but individual languages adapt spelling and endings to their own conventions — hence “metronidasool” in Estonian. International medical terminology databases identify the two as the same active ingredient. The same pattern produces the brand names you may also encounter: Flagyl is the best-known original brand, marketed by Sanofi, while generic manufacturers sell the same active ingredient under its generic name, and topical rosacea preparations are sold under names such as Rozex and MetroGel by Galderma. Different names, same active ingredient — but always check the packaging and your prescription, because brand, form, and strength are separate facts from the ingredient name.
This naming pattern is also why search results for “metronidasool” can look thin or confusing in English. Most major English-language health resources publish under “metronidazole”, so searching the English name returns far more complete information. If you are researching a medicine you have been given under a foreign name, searching the international name is usually the fastest route to reliable guidance — and then confirming the details with your pharmacist.
What we do not know: your situation
A briefing can describe a medicine in general, but it cannot tell you whether this medicine is right for you, what dose you need, how long to take it, what to do if you miss a dose, or how it interacts with your other medicines. Those answers depend on your diagnosis, your medical history, your other treatments, and local guidance, and they belong to the professional who prescribed it. Be especially careful with two common errors: stopping an antimicrobial early because you feel better, and sharing a prescribed medicine with someone else who has similar symptoms. Both can cause harm and contribute to resistance.
Availability also varies by country. In some places metronidazole is prescription-only; in others, certain forms may be available differently. Rules, brand availability, and packaging differ, so do not assume that what applies in one country applies in another.
Questions readers keep asking
Readers encountering metronidasool usually ask the same few questions, and they deserve clear answers within the limits of general information. First, why would a doctor choose this medicine over another antibiotic? Because its activity is narrow and specific: it targets anaerobic bacteria and certain parasites that many common antibiotics do not cover well, which makes it the right tool for a defined set of infections and the wrong tool for many others. Prescribers choose it for the organism and the site involved, not because it is a general-purpose antibiotic. Second, can it be taken with other medicines? That depends on the combination, and the disulfiram interaction and the alcohol caution are the two best-known examples — but the full interaction list is longer and patient-specific, which is why a pharmacist’s review of your complete medicine list matters more than any general article. Third, what should you do if you experience side effects? Mild nausea or a metallic taste is commonly reported, but anything neurological — seizures, visual changes, weakness, numbness, tingling — or any sign of allergy should prompt immediate medical advice rather than waiting for the next dose. Finally, a practical point for travellers and expatriates: if you are given a medicine abroad under a local name you do not recognise, ask the pharmacist to confirm the international nonproprietary name and write it down. That one step turns a confusing foreign label into a searchable, verifiable fact, and it works for metronidasool just as it works for any other localised drug name.
The bottom line
Metronidasool is metronidazole under its Estonian name: a nitroimidazole antimicrobial used against certain anaerobic bacteria and protozoal parasites, available in tablets, liquids, creams, gels, and injections, with well-documented uses, side effects, and cautions. What we know is the medicine’s identity and its general profile. What we do not know — and what no briefing should pretend to know — is the right treatment for any individual reader. For that, talk to your prescriber or pharmacist. And if you want to see how the same name-versus-identity problem plays out with a non-medical term, our briefing on unfamiliar health-adjacent terms applies the same discipline: identify the thing first, then report only what the evidence supports.